Filing Details
- Accession Number:
- 0001209191-16-095844
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-04 18:53:31
- Reporting Period:
- 2016-02-02
- Filing Date:
- 2016-02-04
- Accepted Time:
- 2016-02-04 18:53:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Corp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-02-02 | 6,875 | $0.01 | 21,812 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2016-02-03 | 2,300 | $89.96 | 19,512 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-02-03 | 1,900 | $91.07 | 17,612 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-02-03 | 662 | $92.43 | 16,950 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-02-03 | 200 | $93.06 | 16,750 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2016-02-02 | 20,625 | $0.00 | 20,625 | $91.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,625 | 2026-02-01 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Restricted stock grant vesting on 2/2/2019, subject to acceleration if certain financial and/or business metrics are achieved.
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $89.96 (range $89.54 to $90.44).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $91.07 (range $90.56 to $91.48).
- Open market sales reported on this line occurred at a weighted average price of $92.43 (range $91.79 to $92.72).
- Open market sales reported on this line occurred at a weighted average price of $93.06 (range $92.98 to $93.14).
- The option vests in 16 quarterly installments from 02/02/2016.
Billionaire Hedge Funds
